{"version":"1.0","provider_name":"3Sixty Pharma Solutions LLC","provider_url":"https:\/\/3sixtypharma.com","author_name":"Admin","author_url":"https:\/\/3sixtypharma.com\/author\/admin\/","title":"Genetically modified T-cell therapy granted enhanced EMA regulatory pathway: KTE-C19","type":"rich","width":600,"height":338,"html":"
Genetically modified T-cell therapy granted enhanced EMA regulatory pathway: KTE-C19<\/a><\/blockquote>